FILE PHOTO: The Pfizer logo is seen in this illustration taken August 3, 2025. REUTERS/Dado Ruvic/Illustration/File Photo

(Reuters) -Pfizer said on Monday it would acquire weight-loss drug developer Metsera for up to $4.9 billion to secure its position in the lucrative obesity treatment market.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)